Law and Economics of Personalized Medicine

Institutional Levers to Foster the Translation of Personalized Medicine
1. Auflage 2018
ISBN: 978-3-658-22073-0
Verlag: Springer

Buch, Englisch, 411 Seiten, Book, Format (B × H): 148 mm x 210 mm, Gewicht: 5743 g

Reihe: Gesundheitsmanagement und Gesundheitsökonomik

The book adds to the discussion about strategic approaches towards the translation of personalized medicine into clinical practice. It stresses the importance of non-science related, institutional barriers. A Law and Economics perspective is applied in order to examine the incentives induced by the barriers. An applied part identifies and evaluates policy levers to foster the translation of personalized medicine into Swiss clinical practice.

Zielgruppe

Research

Autoren/Hrsg.

Bosshard, Karin

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Public Health, Gesundheitsmanagement, Gesundheitsökonomie, Gesundheitspolitik
• Rechtswissenschaften Ausländisches Recht Schweiz
• Wirtschaftswissenschaften Volkswirtschaftslehre Gesundheitsökonomie

Inhaltsverzeichnis

Overview of terminologies used in the context of personalized medicine.- Description of personalized medicine’s impact on the healthcare landscape.- Identification and analysis of the institutional barriers to the translation of personalized medicine into clinical practice.- Analysis of institutional barriers to the translation of personalized medicine in Switzerland.- Identification and evaluation of institutional levers to foster the translation of personalized medicine into Swiss clinical practice.

Über Autor(innen)

Dr. Karin Bosshard wrote this book during her time with a globally leading management consultancy where she was working as a strategy consultant. The author is currently working at an international pharmaceutical and diagnostics company and is a lecturer at the University of St. Gallen.